# mRNA

CSPC Pharma Pivots to Next-Gen Cell Therapy with mRNA-Based CAR-T Clinical Approval

CSPC Pharmaceutical Group has received Chinese regulatory approval to begin clinical trials for SYS6063, a dual-target CAR-T therapy delivered via mRNA-LNP technology. This milestone reflects a strategic shift toward non-viral delivery systems that could make advanced cancer treatments more scalable and cost-effective.

NeTe2026年6月2日 11:08

#CSPC Pharmaceutical#mRNA#CAR-T

High-tech radiotherapy machine in a hospital setting, essential for cancer treatment.

Science

mRNA’s New Frontier: MIT Breakthrough Signals an End to ‘Untreatable’ Solid Tumors

Researchers from MIT and MGH have developed a groundbreaking mRNA-based adjuvant that cleared solid tumors in aggressive animal models. By reprogramming dendritic cells to enhance T-cell responses, the study published in Nature Biotechnology offers a potential breakthrough for treating 'cold' tumors that are currently resistant to standard immunotherapy.

NeTe2026年5月13日 23:23

#mRNA#Oncology#MIT